These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10975510)

  • 1. Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients.
    Couban S; Messner HA; Andreou P; Egan B; Price S; Tinker L; Meharchand J; Forrest DL; Lipton J
    Biol Blood Marrow Transplant; 2000; 6(4A):422-7. PubMed ID: 10975510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation.
    Isola L; Scigliano E; Fruchtman S
    Biol Blood Marrow Transplant; 2000; 6(4A):428-33. PubMed ID: 10975511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and feasibility of granulocyte colony-stimulating factor (G-CSF) primed bone marrow (BM) using three days of G-CSF priming as stem cell source for pediatric allogeneic BM transplantation.
    Hussein AA; Sharma S; Al-Zaben A; Frangoul H
    Pediatr Transplant; 2014 Sep; 18(6):625-30. PubMed ID: 25041793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF.
    Isola LM; Scigliano E; Skerrett D; Shank B; Ross V; Najfeld V; Fruchtman S
    Bone Marrow Transplant; 1997 Dec; 20(12):1033-7. PubMed ID: 9466275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H; Wake A; Yamasaki Y; Izumi Y
    Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective.
    Couban S; Dranitsaris G; Andreou P; Price S; Tinker L; Foley R; Walker IR; Jamal S; Jamal N; Spaner D; Lipton J; Meharchand J; Messner HA
    Bone Marrow Transplant; 1998 Dec; 22(12):1199-205. PubMed ID: 9894724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences.
    Kim H; Kang HJ; Lee JW; Park KD; Shin HY; Ahn HS
    Ann Hematol; 2012 May; 91(5):751-758. PubMed ID: 22076065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies from HLA-matched siblings.
    Watanabe T; Kajiume T; Abe T; Kawano Y; Iwai A; Iwai T; Takaue Y; Kuroda Y
    Med Pediatr Oncol; 2000 Mar; 34(3):171-6. PubMed ID: 10696122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
    Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
    Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study.
    Frangoul H; Nemecek ER; Billheimer D; Pulsipher MA; Khan S; Woolfrey A; Manes B; Cole C; Walters MC; Ayas M; Ravindranath Y; Levine JE; Grupp SA
    Blood; 2007 Dec; 110(13):4584-7. PubMed ID: 17827386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.
    Zhang C; Chen XH; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Gong Y; Zeng DF; Wang QY
    Transfus Med; 2010 Jun; 20(3):169-77. PubMed ID: 20136781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and graft characteristics in pediatric hematopoietic stem cell transplantation: Effect of granulocyte-colony stimulating factor priming.
    Fettah A; Özbek N; Azık F; Tavil B; Özgüner M; Avcı Z; Işık P; Yaralı N; Uçkan D; Tunç B
    Transfus Apher Sci; 2015 Jun; 52(3):332-8. PubMed ID: 25779226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients.
    Damiani D; Fanin R; Silvestri F; Grimaz S; Infanti L; Geromin A; Cerno M; Michieli M; Rinaldi C; Savignano C; Trani G; Fiacchini M; Baccarani M
    Blood; 1997 Jul; 90(1):36-42. PubMed ID: 9207435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
    Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of allogeneic G-CSF-stimulated bone marrow transplantation: harvest, engraftment, and graft-versus-host disease.
    Ostronoff M; Ostronoff F; Souto Maior P; Matias C; Calixto R; Sucupira A; Domingues M; Florencio R; Tagliari C
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):729-33. PubMed ID: 16785062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Administration of leukemic granulocyte colony-stimulating factor to donors: the changes in donor bone marrow cell composition and the transplantation outcome].
    Ji S; Chen H; Wang H; Yan H; Pan S
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):834-7. PubMed ID: 16206675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.